Effect of the Escherichia coli EMO strain on experimental infection by Salmonella enterica serovar Typhimurium in gnotobiotic mice

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 7, 2004, Pages 1005-1013

  Lima Filho, J V M ^a   Vieira, L Q ^b   Arantes, R M E ^b   Nicoli, J R ^b  

^a UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Escherichia coli; Gnotobiotic mice; Probiotic; Salmonella

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BACTERIUM ISOLATION; COLON MUCOSA; CONTROLLED STUDY; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GNOTOBIOTICS; HISTOPATHOLOGY; ILEUM MUCOSA; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PLASMA CLEARANCE; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; SPLEEN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM;

EID: 3543130182     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004000700009     Document Type: Article

References (25)

1. WHO (1994). Scientific Working Group on Monitoring and Management of Bacterial Resistance to Antimicrobial Agents. WHO, Geneva, Switzerland.
2. Fuller R (1992). Probiotics: the Scientific Basis. Chapman & Hall, London, UK.
3. Vandenbergh PA (1993). Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiology Reviews, 12: 221-238.
4. Bernet MF, Brassart D, Neeser JR & Servin AL (1994). Lactobacillus acidophilus LA1 binds to human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut, 35: 483-489.
5. Czerucka D, Roux I & Rampal P (1994). Saccharomyces boulardii inhibits secretaguoge-mediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells. Gastroenterology, 106: 65-72.
6. Brandao RL, Castro IM, Bambirra EA, Amaral SC, Fietto LG, Tropia MJM, Neves M J, Santos RG, Gomes NCM & Nicoli JR (1998). Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Applied and Environmental Microbiology, 64: 564-568.
7. Machado Caetano JA, Parames MT, Babo MJ, Santos A, Bandeira Ferreira A, Freitas AA, Clemente Coelho MR & Mateus AM (1986). Immunopharmacological effects of Saccharomyces boulardii in healthy volunteers. International Journal of Immunopharmacology, 8: 245-249.
8. Rodrigues ACP, Nardi RM, Bambirra EA, Vieira EC & Nicoli JR (1996). Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice. Journal of Applied Bacteriology, 81: 251-256.
9. Silva AM, Bambirra EA, Oliveira AL, Souza PP, Gomes DA, Vieira EC & Nicoli JR (1999). Protective effect of bifidus milk on the experimental infection with Salmonella enteritidis subsp. typhimurium in conventional and gnotobiotic mice. Journal of Applied Microbiology, 86: 331-336.
10. Neumann E, Oliveira MAP, Cabral CM, Moura LN, Nicoli JR, Vieira EC, Cara DC, Podoprigora GI & Vieira LQ (1998). Monoassociation with Lactobacillus acidophilus H2B20 stimulates the immune defense mechanisms of germfree mice. Brazilian Journal of Medical and Biological Research, 31: 1565-1573.
11. IgA production and the phagocytic system of gnotobiotic mice. Journal of Applied Microbiology, 89: 404-414.
12. Duval-Iflah Y, Ouriet MF, Moreau C, Daniel N, Gabilan JC & Raibaud P (1982). Implantation précoce d'une souche de Escherichia coli dans I'intestin du nouveau-né humain: effet de barriè re vis-à-vis de souches de E, coli antibiorésistantes. Annales de Microbiologie (Institut Pasteur), 133A: 393-408.
13. Lodinová-Zádniková R, Tlaskalova-Hogenová H & Sonnenborn U (1996). Local and serum antibody response in full-term and premature infants after artificial colonization of the digestive intestine with Escherichia coli strain Nissle 1917 (Mutaflor). Pediatric Allergy and Immunology, 62: 4608-4613.
14. Kruiz W, Schutz E, Fric P, Fixa B, Judmaier G & Stolte M (1997). Double-bind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Alimentary Pharmacology and Therapeutics, 11: 853-858.
15. Jansen G J, Wildeboer-Veloo AC, van de Waaij D & Degener JE (1998). Escherichia coli as a probiotic? Infection, 26: 232-233.
16. Araujo PCR, Nardi RD, Martins C, Raibaud P, Duval-Iflah Y & Nicoli JR (1996). Use of an Escherichia coli as probiotic for piglets. Microecology and Therapy, 24: 317-320.
17. Figueiredo PP, Vieira EC, Nicoli JR, Nardi RD, Raibaud P, Duval-Iflah Y & Penna FJ (2001). Influence of oral inoculation with Escherichia coli EMO on the frequency of diarrhea during the first year of life in human newborns. Journal of Pediatric Gastroenterology and Nutrition, 33: 70-74.
18. Pleasants JR (1974). Gnotobiotics. In: Melby EC & Altman NH (Editors), Handbook of Laboratory Animal Science. CRC Press, Cleveland, OH, USA.
19. National Research Council (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC, USA.
20. Hudault S, Raibaud P, Ducluzeau R & Bridonneau C (1982). Effet antagoniste à l'égard de Clostridium perfringens exercé par des souches de Clostridium isolées de la microflore de souris holoxêniques dans le tube digestif de souris gnotoxêniques. Annales de Microbiologie (Institut Pasteur), 133A: 443-459.
21. Lima Filho JVM, Vieira EC & Nicoli JR (2000). Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp, typhimurium. Journal of Applied Microbiology, 88: 365-370.
22. Hudault S, Guignot J & Servin AL (2001). Escherichia coli strains colonising the gastrointestinal tract protect germ-free mice against Salmonella typhimurium infection. Gut, 49: 47-55.
23. Perdigon G, Alvarez S, Rachid M, Aguero G & Gobbato N (1995). Immune system stimulation by probiotics. Journal of Dairy Science, 78: 1597-1606.
24. Tejada-Simon MV, Lee JH, Ustunol Z & Pestka JJ (1999). Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice. Journal of Dairy Science, 82: 649-660.
25. Perdigon G, Nader de Macias ME, Alvarez S, Oliver G & Ruiz Holgado AAP (1986). Effect of perorally administered lactobacilli on macrophage activation in mice. Infection and Immunity, 53: 404-410.